Follow

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Follow
LinkedIN Twitter Instagram Youtube
Contact
LinkedIN Twitter Instagram Youtube

‎Avalon Pharma recommends transfer of SAR 25.3M to retained earnings

by
April 17, 2025
‎Avalon Pharma recommends transfer of SAR 25.3M to retained earnings ‎Avalon Pharma recommends transfer of SAR 25.3M to retained earnings

​‎

Logo ofMiddle East Pharmaceutical Industries Co. (Avalon Pharma)

Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) board recommended today, April 17, transferring the statutory reserve balance of SAR 25.3 million, as per 2024 financial report, to the retained earnings, according to a statement to Tadawul.

Advertisement

For more news on listed companies

 

‎

Logo ofMiddle East Pharmaceutical Industries Co. (Avalon Pharma)

Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) board recommended today, April 17, transferring the statutory reserve balance of SAR 25.3 million, as per 2024 financial report, to the retained earnings, according to a statement to Tadawul.

For more news on listed companies

by
Updated
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement

Read more